Do Cosentyx and Methotrexate Increase Side Effects Together?
Yes, combining Cosentyx (secukinumab) with methotrexate can raise the risk of certain side effects, mainly infections and lab abnormalities, though serious events remain uncommon in studies.[1][2]
Clinical trials for Cosentyx in psoriasis and psoriatic arthritis tested the combo with methotrexate. Patients on both had higher rates of neutropenia (low white blood cells, 3% vs. 1% on Cosentyx alone) and mild infections like upper respiratory issues.[1] No big jumps in severe infections or other major risks showed up, but monitoring blood counts is standard.[2]
What Infections Are Patients Reporting Most?
Upper respiratory tract infections top the list (15-20% in combo users), along with nasopharyngitis. Candida infections edged up slightly (2-3%). Prescribing info flags heightened infection risk with immunosuppressants like methotrexate, advising against live vaccines.[3]
How Does Liver Risk Change with the Combo?
Methotrexate alone carries hepatotoxicity risk, but Cosentyx doesn't amplify it much—liver enzyme elevations stayed low (under 2%) in trials. Still, docs check liver function regularly, especially in long-term use.[1][2]
Are There Differences in Psoriasis vs. Arthritis Patients?
In psoriasis trials, combo use showed no excess serious adverse events over Cosentyx solo. Psoriatic arthritis data mirrors this: infection rates similar, but neutropenia more frequent (6% vs. 1%). Real-world use reports similar patterns, with no new safety signals.[1][4]
What Do Guidelines Say About Monitoring?
Rheumatology groups like GRAPPA recommend the combo for tough psoriatic arthritis cases but stress baseline labs, monthly bloodwork early on, and infection vigilance. Stop methotrexate if neutropenia hits grade 3+.[2][5]
Any Long-Term Data or Rare Risks?
Two-year extension studies found no cumulative side effect spikes; dropout rates for safety were low (under 5%). Rare cases include severe neutropenia resolving after stopping drugs. No increased malignancy or heart risks noted.[1]
Sources
[1]: Novartis Cosentyx Prescribing Information
[2]: FDA Label for Secukinumab
[3]: Drugs.com Cosentyx-Methotrexate Interaction
[4]: JAAD Psoriasis Safety Review
[5]: GRAPPA Guidelines 2021